Evidence map›Paper›PMID 40657543›Full record

ArticleBio-protocol2025

Cryopreservation of Bulk-Produced Primary Rat Oligodendrocyte Progenitor Cells.

Hanki Kim, Ramsha Afzal, Bum Jun Kim, Hyo Jin Cho, Jun Young Choi

Abstract read
In one paragraph

Article in Bio-protocol, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hanki KimResearch Institute for Basic Sciences, Ajou University, Suwon, South Korea.
Ramsha AfzalDepartment of Brain Science, Ajou University School of Medicine, Suwon, South Korea.
Bum Jun KimDepartment of Brain Science, Ajou University School of Medicine, Suwon, South Korea.
Hyo Jin ChoDepartment of Brain Science, Ajou University School of Medicine, Suwon, South Korea.
Jun Young ChoiDepartment of Brain Science, Ajou University School of Medicine, Suwon, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary oligodendrocyte cultures are a crucial driving force for in vitro research on oligodendrocytes (OLs) and myelin. Various methods are available to obtain oligodendrocyte lineage cells, primarily from neonatal rodent brains or human induced pluripotent stem cells (iPSCs). In this protocol, we describe a step-by-step procedure for detaching and cryopreserving primary rat oligodendrocyte progenitor cells (OPCs), followed by the thawing, proliferation, and differentiation of the cryopreserved OPCs. After freezing in a serum-free cryopreservation medium, the OPCs can be preserved at -80 °C for up to two months without notable changes in viability, proliferation, or differentiation into mature OLs. Cryopreserved OPCs can be differentiated into mature OLs with robust myelin processes and the capacity to wrap around neuron-mimicking structures. Combined with the author's method for primary OL culture, which allows for bulk production of OPCs, OPC cryopreservation may substantially improve the efficiency of in vitro OL research. Key features • This protocol recommends the use of a specific culture method that enables the simple, bulk production of primary rat OPCs. • Through this protocol, researchers may obtain large numbers of cryopreserved OPCs, which can be reserved for up to two months. • This protocol facilitates the planning of in vitro experiments and reduces the effort required to maintain adequate numbers of primary OPCs for large-scale experiments.

Indexed as

Bulk productionCell reserveCryopreservationOligodendrocyte (OL)Oligodendrocyte progenitor cell (OPC)

Identifiers

PMID40657543
PMCPMC12254587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.